CONMED (NYSE:CNMD) Given New $120.00 Price Target at Stifel Nicolaus
CONMED (NYSE:CNMD – Free Report) had its target price lowered by Stifel Nicolaus from $136.00 to $120.00 in a research report released on Thursday morning, Benzinga reports. The firm currently has a buy rating on the stock. A number of other equities research analysts have also recently commented on the company. Piper Sandler raised their […]
More Stories
Canada One Mining (CVE:CONE) Trading 33.3% Higher – Time to Buy?
Shares of Canada One Mining Corp. (CVE:CONE – Get Free Report) were up 33.3% during mid-day trading on Saturday ....
Indus Gas (LON:INDI) Stock Price Down 4.2% – Time to Sell?
Shares of Indus Gas Limited (LON:INDI – Get Free Report) traded down 4.2% during trading on Saturday . The company...
Vanguard S&P Mid-Cap 400 ETF (NYSEARCA:IVOO) Sees Large Volume Increase – Here’s Why
Shares of Vanguard S&P Mid-Cap 400 ETF (NYSEARCA:IVOO – Get Free Report) saw strong trading volume on Thursday . 49,090...
KBR (NYSE:KBR) Trading 7.8% Higher – What’s Next?
Shares of KBR, Inc. (NYSE:KBR – Get Free Report) shot up 7.8% during mid-day trading on Thursday . The stock...
Cintas (NASDAQ:CTAS) Shares Gap Down – Here’s Why
Cintas Co. (NASDAQ:CTAS – Get Free Report)’s stock price gapped down before the market opened on Thursday . The stock...
Pitney Bowes Repays $75 Million in Senior Secured Notes to Oaktree Capital Management
Pitney Bowes Inc., a leading technology company providing commerce solutions in the areas of shipping, mailing, and financial services, today...